ETFs

Kainos Group (LON:KNOS) Receives Buy Rating from Canacc...

Kainos Group (LON:KNOS – Get Free Report)‘s stock had its “buy” rating reaffirme...

Primary Health Properties (LON:PHP) Earns Buy Rating fr...

Primary Health Properties (LON:PHP – Get Free Report)‘s stock had its “buy” rati...

Shore Capital Reiterates House Stock Rating for Savanna...

Savannah Energy (LON:SAVE – Get Free Report)‘s stock had its “house stock” ratin...

Canaccord Genuity Group Lowers Akoya Biosciences (NASDA...

Akoya Biosciences (NASDAQ:AKYA – Get Free Report) had its price objective reduce...

Morgan Stanley Lowers Allegiant Travel (NASDAQ:ALGT) Pr...

Allegiant Travel (NASDAQ:ALGT – Get Free Report) had its price objective cut by ...

Benchmark Lowers Biofrontera (NASDAQ:BFRI) Price Target...

Biofrontera (NASDAQ:BFRI – Get Free Report) had its price target lowered by anal...

Morgan Stanley Boosts Brighthouse Financial (NASDAQ:BHF...

Brighthouse Financial (NASDAQ:BHF – Get Free Report) had its target price booste...

Morgan Stanley Has Lowered Expectations for Contineum T...

Contineum Therapeutics (NASDAQ:CTNM – Get Free Report) had its price objective d...

Campbell’s (NASDAQ:CPB) Given New $33.00 Price Target a...

Campbell’s (NASDAQ:CPB – Get Free Report) had its price target lowered by resear...

Maplebear (NASDAQ:CART) Stock Price Expected to Rise, L...

Maplebear (NASDAQ:CART – Get Free Report) had its price objective increased by e...

Maxim Group Initiates Coverage on CERo Therapeutics (NA...

Analysts at Maxim Group began coverage on shares of CERo Therapeutics (NASDAQ:CE...

Beam Global (NASDAQ:BEEM) Price Target Lowered to $4.00...

Beam Global (NASDAQ:BEEM – Get Free Report) had its price objective decreased by...

Canadian Solar (NASDAQ:CSIQ) Stock Price Expected to Ri...

Canadian Solar (NASDAQ:CSIQ – Get Free Report) had its target price raised by eq...

Mizuho Increases Advanced Micro Devices (NASDAQ:AMD) Pr...

Advanced Micro Devices (NASDAQ:AMD – Get Free Report) had its target price upped...

HC Wainwright Reiterates Buy Rating for Atyr PHARMA (NA...

Atyr PHARMA (NASDAQ:ATYR – Get Free Report)‘s stock had its “buy” rating reaffir...

HC Wainwright Reaffirms Buy Rating for CASI Pharmaceuti...

CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report)‘s stock had its “buy” ratin...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.